BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 33764622)

  • 1. Association Between Microscopic Colitis and Parkinson's Disease in a Swedish Population.
    Kang X; Ploner A; Roelstraete B; Khalili H; Williams DM; Pedersen NL; Ludvigsson JF; Wirdefeldt K
    Mov Disord; 2021 Aug; 36(8):1919-1926. PubMed ID: 33764622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microscopic Colitis and Risk of Incident Acute Pancreatitis: A Nationwide Population-Based Matched Cohort Study.
    Bergman D; Roelstraete B; Olén O; Lindkvist B; Ludvigsson JF
    Am J Gastroenterol; 2023 Nov; 118(11):2041-2051. PubMed ID: 37171015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microscopic Colitis and Risk of Incident Psoriasis: A Nationwide Population-Based Matched Cohort Study.
    Bergman D; Roelstraete B; Sun J; Ebrahimi F; Lidström R; Svedbom A; Ståhle M; Ludvigsson JF
    Clin Epidemiol; 2024; 16():213-225. PubMed ID: 38567370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes Zoster and Risk of Incident Parkinson's Disease in US Veterans: A Matched Cohort Study.
    Tunnicliffe L; Weil RS; Breuer J; Rodriguez-Barradas MC; Smeeth L; Rentsch CT; Warren-Gash C
    Mov Disord; 2024 Feb; 39(2):438-444. PubMed ID: 38226430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediagnostic Blood Metal Levels and the Risk of Parkinson's Disease: A Large European Prospective Cohort.
    Zhao Y; Ray A; Broberg K; Kippler M; Lill CM; Vineis P; Katzke VA; Rodriguez-Barranco M; Chirlaque MD; Guevara M; Gómez JH; Hansen J; Panico S; Middleton LT; Masala G; Pala V; Vinagre-Aragon A; Zibetti M; Vermeulen R; Peters S
    Mov Disord; 2023 Dec; 38(12):2302-2307. PubMed ID: 37675653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol Consumption and Risk of Parkinson's Disease: Data From a Large Prospective European Cohort.
    Peters S; Gallo V; Vineis P; Middleton LT; Forsgren L; Sacerdote C; Sieri S; Kyrozis A; Chirlaque MD; Zamora-Ros R; Hansson O; Petersson J; Katzke V; Kühn T; Mokoroa O; Masala G; Ardanaz E; Panico S; Bergmann MM; Key TJ; Weiderpass E; Ferrari P; Vermeulen R
    Mov Disord; 2020 Jul; 35(7):1258-1263. PubMed ID: 32357270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing incidence of Parkinson's disease in patients with epilepsy: A Nationwide cohort study.
    Hwang YS; Kang MG; Yeom SW; Jeong CY; Shin BS; Koh J; Kim JS; Kang HG
    J Neurol Sci; 2024 Mar; 458():122891. PubMed ID: 38310734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Risk of Parkinson's Disease After Rheumatoid Arthritis Diagnosis: A Nested Case-Control Study with Matched Cases and Controls.
    Bacelis J; Compagno M; George S; Pospisilik JA; Brundin P; Naluai ÅT; Brundin L
    J Parkinsons Dis; 2021; 11(2):821-832. PubMed ID: 33682730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroticism and Risk of Parkinson's Disease: A Meta-Analysis.
    Terracciano A; Aschwanden D; Stephan Y; Cerasa A; Passamonti L; Toschi N; Sutin AR
    Mov Disord; 2021 Aug; 36(8):1863-1870. PubMed ID: 33817817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of time spent outdoors with the risk of Parkinson's disease: a prospective cohort study of 329,359 participants.
    Hu L; Shi Y; Zou X; Lai Z; Lin F; Cai G; Liu X
    BMC Neurol; 2024 Jan; 24(1):10. PubMed ID: 38166701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarifying the association between Parkinson's disease and vitiligo: a population-based large-scale study.
    Kridin K; Ofir L; Weinstein O; Badarny S
    Front Neurol; 2024; 15():1387404. PubMed ID: 38835998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dry-Cleaning Chemicals and a Cluster of Parkinson's Disease and Cancer: A Retrospective Investigation.
    Dorsey ER; Kinel D; Pawlik ME; Zafar M; Lettenberger SE; Coffey M; Auinger P; Hylton KL; Shaw CW; Adams JL; Barbano R; Braun MK; Schwarz HB; Lawrence BP; Kieburtz K; Tanner CM; de Miranda BR; Goldman SM
    Mov Disord; 2024 Mar; 39(3):606-613. PubMed ID: 38389433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital-treated infections and subsequent Parkinson's disease risk: a register-based sibling comparison study.
    Vingeliene S; Hiyoshi A; Lentjes MAH; Brummer RJ; Fall K; Montgomery S
    Brain Commun; 2024; 6(2):fcae098. PubMed ID: 38562309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distressing dreams and risk of Parkinson's disease: A population-based cohort study.
    Otaiku DAI
    EClinicalMedicine; 2022 Jun; 48():101474. PubMed ID: 35783487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the association between microscopic colitis and celiac disease: A comprehensive analysis using the national in-patient data (2016-2019).
    Altawili A; Albalawi MA; Albalawi SA; Alyami DM; Alatawi AA; Albalawi KS; Alghassab MA; Alotaibi TFO; Althobaiti AAH; Abu-Zaid A
    Saudi J Gastroenterol; 2024 May; ():. PubMed ID: 38708884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of diabetes control status on the progression of Parkinson's disease: A prospective study.
    Ou R; Wei Q; Hou Y; Zhang L; Liu K; Lin J; Jiang Z; Song W; Cao B; Shang H
    Ann Clin Transl Neurol; 2021 Apr; 8(4):887-897. PubMed ID: 33764699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease.
    Schiess M; Suescun J; Doursout MF; Adams C; Green C; Saltarrelli JG; Savitz S; Ellmore TM
    Mov Disord; 2021 Aug; 36(8):1825-1834. PubMed ID: 33772873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease.
    Rosebraugh M; Voight EA; Moussa EM; Jameel F; Lou X; Zhang GGZ; Mayer PT; Stolarik D; Carr RA; Enright BP; Liu W; Facheris MF; Kym PR
    Ann Neurol; 2021 Jul; 90(1):52-61. PubMed ID: 33772855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson's disease.
    O'Callaghan C; Hezemans FH; Ye R; Rua C; Jones PS; Murley AG; Holland N; Regenthal R; Tsvetanov KA; Wolpe N; Barker RA; Williams-Gray CH; Robbins TW; Passamonti L; Rowe JB
    Brain; 2021 Sep; 144(8):2513-2526. PubMed ID: 33783470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease and mitophagy: an emerging role for LRRK2.
    Singh F; Ganley IG
    Biochem Soc Trans; 2021 Apr; 49(2):551-562. PubMed ID: 33769432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.